Free Trial

1,570,550 Shares in Avantor, Inc. (NYSE:AVTR) Purchased by Raymond James Financial Inc.

Avantor logo with Medical background
Remove Ads

Raymond James Financial Inc. bought a new position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor bought 1,570,550 shares of the company's stock, valued at approximately $33,091,000. Raymond James Financial Inc. owned 0.23% of Avantor at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. State Street Corp grew its stake in shares of Avantor by 58.0% in the third quarter. State Street Corp now owns 22,368,244 shares of the company's stock valued at $578,666,000 after buying an additional 8,206,695 shares in the last quarter. The Manufacturers Life Insurance Company grew its stake in Avantor by 653.0% during the 3rd quarter. The Manufacturers Life Insurance Company now owns 6,174,736 shares of the company's stock valued at $159,740,000 after purchasing an additional 5,354,678 shares in the last quarter. FMR LLC grew its stake in Avantor by 557.2% during the 3rd quarter. FMR LLC now owns 4,675,283 shares of the company's stock valued at $120,950,000 after purchasing an additional 3,963,912 shares in the last quarter. Janus Henderson Group PLC grew its stake in Avantor by 18.2% during the 3rd quarter. Janus Henderson Group PLC now owns 17,692,705 shares of the company's stock valued at $457,710,000 after purchasing an additional 2,719,615 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its holdings in Avantor by 146.5% during the 3rd quarter. Principal Financial Group Inc. now owns 2,628,372 shares of the company's stock worth $67,996,000 after buying an additional 1,562,018 shares during the last quarter. 95.08% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling at Avantor

In related news, EVP James Bramwell sold 3,758 shares of the firm's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total transaction of $65,877.74. Following the sale, the executive vice president now owns 87,379 shares of the company's stock, valued at approximately $1,531,753.87. This trade represents a 4.12 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CAO Steven W. Eck sold 4,907 shares of the firm's stock in a transaction on Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $86,019.71. Following the sale, the chief accounting officer now directly owns 40,604 shares in the company, valued at $711,788.12. The trade was a 10.78 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.50% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts have commented on AVTR shares. Barclays reduced their target price on Avantor from $26.00 to $23.00 and set an "overweight" rating on the stock in a report on Monday, February 10th. UBS Group reissued a "neutral" rating and issued a $25.00 price target (down previously from $29.00) on shares of Avantor in a report on Friday, January 17th. Raymond James reissued an "outperform" rating and issued a $24.00 price target (down previously from $26.00) on shares of Avantor in a report on Monday, February 10th. Wells Fargo & Company cut their price target on Avantor from $28.00 to $25.00 and set an "overweight" rating on the stock in a report on Monday, February 10th. Finally, Citigroup cut their price target on Avantor from $22.00 to $18.00 and set a "neutral" rating on the stock in a report on Tuesday, March 4th. Three analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $25.50.

Remove Ads

Check Out Our Latest Stock Analysis on AVTR

Avantor Trading Up 0.2 %

Shares of AVTR opened at $15.83 on Friday. Avantor, Inc. has a 1 year low of $15.37 and a 1 year high of $28.00. The company has a current ratio of 1.07, a quick ratio of 0.70 and a debt-to-equity ratio of 0.54. The stock has a 50 day simple moving average of $19.62 and a 200-day simple moving average of $22.12. The stock has a market cap of $10.78 billion, a PE ratio of 15.22, a PEG ratio of 1.55 and a beta of 1.30.

Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings results on Wednesday, February 12th. The company reported $0.27 earnings per share for the quarter, beating analysts' consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same quarter in the previous year, the business posted $0.22 earnings per share. On average, sell-side analysts predict that Avantor, Inc. will post 1.06 EPS for the current fiscal year.

About Avantor

(Free Report)

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

Featured Articles

Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR - Free Report).

Institutional Ownership by Quarter for Avantor (NYSE:AVTR)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Avantor Right Now?

Before you consider Avantor, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Avantor wasn't on the list.

While Avantor currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

These Are the 3 Stocks Most Likely to SPLIT in 2025

These Are the 3 Stocks Most Likely to SPLIT in 2025

MarketBeat analyst Thomas Hughes breaks down why companies split their stock and reveals his top three picks most likely to split next year.

Related Videos

Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
Elon Musk’s First 100 Days of DOGE: 3 AI Stocks Ready to Soar
5 Stocks to BUY NOW in February 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads